Oritavancin CAS:171099-57-3

  • Description
Product Detail


Product Information

CAS NO.171099-57-3 1.png
Product NameOritavancin
SynonymsLY 333328
FormulaC86H97Cl3N10O26
Molecular Weight1793.12
Spec / Purity98%min
Supply Capacity
DetailsOritavancin (LY333328/Orbactiv) is a novel semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections. In December 2008, the US FDA declined to approve it without additional studies, and an EU application was withdrawn. In 2009, the development rights were acquired by The Medicines Company, which has completed clinical trials and submitted a new drug application to the FDA in February 2014. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections in the United States. Its chemical structure is similar to vancomycin. It is a lipoglycopeptide.
Send your message to this supplier
To:  

Shanghai Biopharmaleader Co.,Ltd

* Content:  

For better quotations, include:

- A self introduction

- Special requests, if any

Quantity:  
  
You May Like
Not exactly what you want? One request, multiple quotations Get Quotations Now >>
Related Searches :
7 YRS Shanghai Biopharmaleader Co.,Ltd
China Mainland Favorites
Transaction Level:
Contact Us

* Quantity:

You May Like